Speaker illustration

Doctor Ashkan Shoamanesh

McMaster University, Hamilton (Canada)

PACIFIC-STROKE - Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study.

Event: ESC Congress 2022

Topic: Prevention

Session: HOT LINE SESSION 5

Thumbnail

This platform is supported by

logo Novo Nordisk